Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17

被引:14
|
作者
Yang, Justin C. [1 ,2 ]
Roman-Urrestarazu, Andres [1 ,3 ]
Brayne, Carol [1 ]
机构
[1] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England
[2] UCL, Fac Brain Sci, Div Psychiat, Dept & Epidemiol & Appl Clin Res, London, England
[3] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Int Hlth, Maastricht, Netherlands
来源
PLOS ONE | 2019年 / 14卷 / 12期
关键词
MEDICATION-ASSISTED TREATMENT; SUBSTANCE-ABUSE TREATMENT; METHADONE-MAINTENANCE; OLDER-ADULTS; BUPRENORPHINE; DETERMINANTS; PHYSICIANS; MORTALITY; BARRIERS; THERAPY;
D O I
10.1371/journal.pone.0226349
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. Methods We draw upon data from the Treatment Episode Data Set-Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. Results Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. Conclusion Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States
    Short, Vanessa L.
    Hand, Dennis J.
    MacAfee, Lauren
    Abatemarco, Diane J.
    Terplan, Mishka
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 89 : 67 - 74
  • [2] Treatment utilization among persons with opioid use disorder in the United States
    Wu, Li-Tzy
    Zhu, He
    Swartz, Marvin S.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2016, 169 : 117 - 127
  • [3] Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
    Hadland, Scott E.
    Bagley, Sarah M.
    Rodean, Jonathan
    Silverstein, Michael
    Levy, Sharon
    Larochelle, Marc R.
    Samet, Jeffrey H.
    Zima, Bonnie T.
    [J]. JAMA PEDIATRICS, 2018, 172 (11) : 1029 - 1037
  • [4] Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon
    Springer, Rachel
    Marino, Miguel
    Bailey, Steffani R.
    Angier, Heather
    O'Malley, Jean P.
    Hoopes, Megan
    Lindner, Stephan
    DeVoe, Jennifer E.
    Huguet, Nathalie
    [J]. ADDICTION, 2019, 114 (10) : 1775 - 1784
  • [5] Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017
    Clemans-Cope, Lisa
    Lynch, Victoria
    Epstein, Marni
    Kenney, Genevieve M.
    [J]. ANNALS OF FAMILY MEDICINE, 2019, 17 (03) : 207 - 211
  • [6] Underutilization of Treatment for Opioid Use Disorder Among Young Adults in the United States
    Frederick, Marva
    [J]. NURSING RESEARCH, 2020, 69 (03) : E181 - E181
  • [7] Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment
    Saloner, Brendan
    Stoller, Kenneth B.
    Barry, Colleen L.
    [J]. PSYCHIATRIC SERVICES, 2016, 67 (06) : 675 - 678
  • [8] Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder
    Ford, Becky R.
    Bart, Gavin
    Grahan, Brian
    Shearer, Riley D.
    Winkelman, Tyler N. A.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 159 - 162
  • [9] Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder in the United States
    MacAfee, Lauren
    Sawyer, Anne
    Terplan, Mishka
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E125 - E125
  • [10] Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a US national sample
    Krawczyk, Noa
    Feder, Kenneth A.
    Fingerhood, Michael I.
    Saloner, Brendan
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 178 : 512 - 518